Providence St. Mary Regional Cancer Center is a clinical research site located in Walla Walla, Washington, United States 99362.
Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.
Providence St. Mary Regional Cancer Center has participated in 8 clinical trials.
Therapeutic areas: Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), Tumors With CDK4/6 Pathway Activation.
Sponsors: Celgene, Pharmacyclics LLC., Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Walla Walla
Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Providence St. Mary Regional Cancer Center has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Providence St. Mary Regional Cancer Center has 8 clinical trials on record. Their work covers Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), Tumors With CDK4/6 Pathway Activation.
Providence St. Mary Regional Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.